Skip to main content

Amylyx Pharmaceuticals, Inc.

AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001658551

In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Members of Congress who traded AMLX

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
1 / 0
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded AMLX
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Chris JacobsRepublican · House · NY11 / 0$8.00KOct 12, 2022Nov 16, 2022

Trades

Every reported trade in Amylyx Pharmaceuticals, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Chris JacobsRepublican · House · NYAMLXAmylyx Pharmaceuticals, Inc.BuySelfOct 12, 2022Nov 16, 202235 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.